Mono Vaccine Market Size, Share, and Outlook, H2-2025 Report- By Type (Meningococcal Vaccine, Japanese Encephalitis Vaccine, Hepatitis Vaccine, Yellow Fever Vaccine, Others) and Companies, 2021-2032
Description
Mono Vaccine Market Outlook
The global Mono Vaccine Market Size is valued at $11.6 Billion in 2025 and is forecast to reach $16.1 Billion in 2032 at a CAGR of 4.8%.
The Mono Vaccine Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Mono Vaccine Market segments across 22 countries from 2021 to 2032. Key segments covered include By Type (Meningococcal Vaccine, Japanese Encephalitis Vaccine, Hepatitis Vaccine, Yellow Fever Vaccine, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Mono Vaccine Market Insights, 2025
The mono vaccine market in 2025 remains a critical pillar in the global immunization landscape, focusing on vaccines targeting a single pathogen to provide specific immunity. Unlike multivalent vaccines, mono vaccines deliver focused protection, which is particularly important for diseases with unique epidemiological profiles or where combination vaccines may dilute immune response. Ongoing advancements involve enhanced antigen design, adjuvant formulations, and novel delivery platforms such as mRNA and viral vectors to improve immunogenicity and durability. The market is influenced by emerging infectious diseases, vaccine hesitancy challenges, and evolving regulatory frameworks emphasizing safety and efficacy. Production scalability and cold chain logistics remain operational considerations. The mono vaccine segment is vital in outbreak containment, booster dose strategies, and immunization in immunocompromised populations where targeted immunity is essential. Continuous research addresses strain variations and vaccine resistance. Strategic partnerships between governments, academia, and industry aim to optimize access and affordability globally.
Five Trends Shaping the Global Mono Vaccine Market in 2025 and Beyond
The global Mono Vaccine Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Mono Vaccine Industry?
The Mono Vaccine Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Mono Vaccine Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Mono Vaccine Market Segment Insights
The Mono Vaccine Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Type (Meningococcal Vaccine, Japanese Encephalitis Vaccine, Hepatitis Vaccine, Yellow Fever Vaccine, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Mono Vaccine Industry Value Chain
The chapter identifies potential companies and their operations across the global Mono Vaccine Industry ecosystem. It assists decision-makers in evaluating global Mono Vaccine Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Mono Vaccine Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Mono Vaccine Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Mono Vaccine Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Mono Vaccine Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Mono Vaccine Market.
Europe Mono Vaccine Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Mono Vaccine Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Mono Vaccine Industry competitiveness. The report analyses the key Mono Vaccine Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Mono Vaccine Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Mono Vaccine Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Mono Vaccine Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Mono Vaccine Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Mono Vaccine Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Mono Vaccine Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes AstraZeneca Plc, Aurobindo Pharma Ltd, Bavarian Nordic AS, China National Pharmaceutical Group Corp, Dynavax Technologies Corp, GlaxoSmithKline Plc, Johnson and Johnson, Merck and Co. Inc, Moderna Inc, Pfizer Inc, Sanofi S.A., Serum Institute of India Pvt. Ltd, Shenzhen Kangtai Biological Products Co. Ltd, Valneva SE, VBI Vaccines Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Mono Vaccine Market Scope
Leading Segments
By Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Hepatitis Vaccine
Yellow Fever Vaccine
Others
Leading Companies
AstraZeneca Plc
Aurobindo Pharma Ltd
Bavarian Nordic AS
China National Pharmaceutical Group Corp
Dynavax Technologies Corp
GlaxoSmithKline Plc
Johnson and Johnson
Merck and Co. Inc
Moderna Inc
Pfizer Inc
Sanofi S.A.
Serum Institute of India Pvt. Ltd
Shenzhen Kangtai Biological Products Co. Ltd
Valneva SE
VBI Vaccines Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Mono Vaccine Market Size is valued at $11.6 Billion in 2025 and is forecast to reach $16.1 Billion in 2032 at a CAGR of 4.8%.
The Mono Vaccine Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Mono Vaccine Market segments across 22 countries from 2021 to 2032. Key segments covered include By Type (Meningococcal Vaccine, Japanese Encephalitis Vaccine, Hepatitis Vaccine, Yellow Fever Vaccine, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Mono Vaccine Market Insights, 2025
The mono vaccine market in 2025 remains a critical pillar in the global immunization landscape, focusing on vaccines targeting a single pathogen to provide specific immunity. Unlike multivalent vaccines, mono vaccines deliver focused protection, which is particularly important for diseases with unique epidemiological profiles or where combination vaccines may dilute immune response. Ongoing advancements involve enhanced antigen design, adjuvant formulations, and novel delivery platforms such as mRNA and viral vectors to improve immunogenicity and durability. The market is influenced by emerging infectious diseases, vaccine hesitancy challenges, and evolving regulatory frameworks emphasizing safety and efficacy. Production scalability and cold chain logistics remain operational considerations. The mono vaccine segment is vital in outbreak containment, booster dose strategies, and immunization in immunocompromised populations where targeted immunity is essential. Continuous research addresses strain variations and vaccine resistance. Strategic partnerships between governments, academia, and industry aim to optimize access and affordability globally.
Five Trends Shaping the Global Mono Vaccine Market in 2025 and Beyond
The global Mono Vaccine Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Mono Vaccine Industry?
The Mono Vaccine Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Mono Vaccine Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Mono Vaccine Market Segment Insights
The Mono Vaccine Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Type (Meningococcal Vaccine, Japanese Encephalitis Vaccine, Hepatitis Vaccine, Yellow Fever Vaccine, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Mono Vaccine Industry Value Chain
The chapter identifies potential companies and their operations across the global Mono Vaccine Industry ecosystem. It assists decision-makers in evaluating global Mono Vaccine Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Mono Vaccine Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Mono Vaccine Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Mono Vaccine Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Mono Vaccine Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Mono Vaccine Market.
Europe Mono Vaccine Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Mono Vaccine Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Mono Vaccine Industry competitiveness. The report analyses the key Mono Vaccine Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Mono Vaccine Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Mono Vaccine Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Mono Vaccine Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Mono Vaccine Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Mono Vaccine Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Mono Vaccine Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes AstraZeneca Plc, Aurobindo Pharma Ltd, Bavarian Nordic AS, China National Pharmaceutical Group Corp, Dynavax Technologies Corp, GlaxoSmithKline Plc, Johnson and Johnson, Merck and Co. Inc, Moderna Inc, Pfizer Inc, Sanofi S.A., Serum Institute of India Pvt. Ltd, Shenzhen Kangtai Biological Products Co. Ltd, Valneva SE, VBI Vaccines Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Mono Vaccine Market Scope
Leading Segments
By Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Hepatitis Vaccine
Yellow Fever Vaccine
Others
Leading Companies
AstraZeneca Plc
Aurobindo Pharma Ltd
Bavarian Nordic AS
China National Pharmaceutical Group Corp
Dynavax Technologies Corp
GlaxoSmithKline Plc
Johnson and Johnson
Merck and Co. Inc
Moderna Inc
Pfizer Inc
Sanofi S.A.
Serum Institute of India Pvt. Ltd
Shenzhen Kangtai Biological Products Co. Ltd
Valneva SE
VBI Vaccines Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
180 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Mono Vaccine Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Mono Vaccine Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Mono Vaccine Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Mono Vaccine Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Mono Vaccine Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Type
- Meningococcal Vaccine
- Japanese Encephalitis Vaccine
- Hepatitis Vaccine
- Yellow Fever Vaccine
- Others
- 6. Global Mono Vaccine Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Mono Vaccine Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Mono Vaccine Market Trends and Growth Opportunities
- 6.2.1 North America Mono Vaccine Market Outlook by Type
- 6.2.2 North America Mono Vaccine Market Outlook by Application
- 6.3 North America Mono Vaccine Market Outlook by Country
- 6.3.1 The US Mono Vaccine Market Outlook, 2021- 2032
- 6.3.2 Canada Mono Vaccine Market Outlook, 2021- 2032
- 6.3.3 Mexico Mono Vaccine Market Outlook, 2021- 2032
- 7. Europe Mono Vaccine Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Mono Vaccine Market Trends and Growth Opportunities
- 7.2.1 Europe Mono Vaccine Market Outlook by Type
- 7.2.2 Europe Mono Vaccine Market Outlook by Application
- 7.3 Europe Mono Vaccine Market Outlook by Country
- 7.3.2 Germany Mono Vaccine Market Outlook, 2021- 2032
- 7.3.3 France Mono Vaccine Market Outlook, 2021- 2032
- 7.3.4 The UK Mono Vaccine Market Outlook, 2021- 2032
- 7.3.5 Spain Mono Vaccine Market Outlook, 2021- 2032
- 7.3.6 Italy Mono Vaccine Market Outlook, 2021- 2032
- 7.3.7 Russia Mono Vaccine Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Mono Vaccine Market Outlook, 2021- 2032
- 8. Asia Pacific Mono Vaccine Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Mono Vaccine Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Mono Vaccine Market Outlook by Type
- 8.2.2 Asia Pacific Mono Vaccine Market Outlook by Application
- 8.3 Asia Pacific Mono Vaccine Market Outlook by Country
- 8.3.1 China Mono Vaccine Market Outlook, 2021- 2032
- 8.3.2 India Mono Vaccine Market Outlook, 2021- 2032
- 8.3.3 Japan Mono Vaccine Market Outlook, 2021- 2032
- 8.3.4 South Korea Mono Vaccine Market Outlook, 2021- 2032
- 8.3.5 Australia Mono Vaccine Market Outlook, 2021- 2032
- 8.3.6 South East Asia Mono Vaccine Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Mono Vaccine Market Outlook, 2021- 2032
- 9. South America Mono Vaccine Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Mono Vaccine Market Trends and Growth Opportunities
- 9.2.1 South America Mono Vaccine Market Outlook by Type
- 9.2.2 South America Mono Vaccine Market Outlook by Application
- 9.3 South America Mono Vaccine Market Outlook by Country
- 9.3.1 Brazil Mono Vaccine Market Outlook, 2021- 2032
- 9.3.2 Argentina Mono Vaccine Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Mono Vaccine Market Outlook, 2021- 2032
- 10. Middle East and Africa Mono Vaccine Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Mono Vaccine Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Mono Vaccine Market Outlook by Type
- 10.2.2 Middle East and Africa Mono Vaccine Market Outlook by Application
- 10.3 Middle East and Africa Mono Vaccine Market Outlook by Country
- 10.3.1 Saudi Arabia Mono Vaccine Market Outlook, 2021- 2032
- 10.3.2 The UAE Mono Vaccine Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Mono Vaccine Market Outlook, 2021- 2032
- 10.3.4 South Africa Mono Vaccine Market Outlook, 2021- 2032
- 10.3.5 Egypt Mono Vaccine Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Mono Vaccine Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- AstraZeneca Plc
- Aurobindo Pharma Ltd
- Bavarian Nordic AS
- China National Pharmaceutical Group Corp
- Dynavax Technologies Corp
- GlaxoSmithKline Plc
- Johnson and Johnson
- Merck and Co. Inc
- Moderna Inc
- Pfizer Inc
- Sanofi S.A.
- Serum Institute of India Pvt. Ltd
- Shenzhen Kangtai Biological Products Co. Ltd
- Valneva SE
- VBI Vaccines Inc
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
